HomeAuthor

prometheusip - Prometheus IP - Page 11

by prometheusip  October 6, 2015

Tara Alvarez, a professor of biomedical engineering at NJIT, will receive an Edison Patent Award later this year from the Research & Development Council of New Jersey for a novel test she and a colleague designed to help eye doctors predict how well their patients will adapt to progressive lenses.

by prometheusip  October 6, 2015

User-centered design will be a top priority as the U.S. Patent and Trademark Office develops its new online patent filing and viewing system, agency CIO John Owens told FedScoop.

by prometheusip  October 6, 2015

The U.S. Patent and Trademark Office debuted a new tool that makes it easier for the public to explore the agency’s patents archive.

by prometheusip  October 6, 2015

MBI announced its innovative biomass pretreatment patent (patent no. 9,102,964) has been issued by the USPTO.

by prometheusip  October 6, 2015

The USPTO has launched two new programs aimed at improving patent quality by joining forces with the Japanese Patent Office (JPO) or the Korean Intellectual Property Office (KIPO) at the initial stages of the patent examination process.

by prometheusip  October 6, 2015

A division bench of the Delhi High Court has reserved its decision on a high-profile patent case that pitted Swiss drug maker Novartis against Cipla over its respiratory drug brand Onbrez.

by prometheusip  September 22, 2015

A patent was awarded to google for its glasses which has a unique auto adjusting capacity to detect the movement of the user and make adjustments accordingly.

by prometheusip  September 22, 2015

India denied the patent for Pfizer on tofacitinib (a rheumatoid arthritis drug). The reason cited was the inability of the company to establish a more active therapeutic efficacy than the active compound.

by prometheusip  September 22, 2015

The patent office guidelines issued have divided the software industry. Some say since the software as in algorithms and computer programmes are protected under copyright it is not essential to patent them whereas the other group says patents are necessary to deter the clone companies.

by prometheusip  September 22, 2015

Suven Life Sciences had announced the grant of five patents in various countries. These patents include the class of selective 5 HT (Hydroxytryptamine) compounds relating to the treatment of cognitive impairment leading to neurodegenerative diseases

Our Wide Range of Services

Hyderabad
Prometheus Patent Services Pvt Ltd.
Plot No:438, SPR Arcade,
1st Floor, TNGO’s Colony Phase 2
Gachibowli, Hyderabad-500032
Telangana, India.
Our locationsWhere to find us?
https://www.prometheusip.com/wp-content/uploads/2020/01/footer-map.png
Get in touchPrometheus IP Social
Prometheus IPHeadquarters
Prometheus Patent Services Pvt Ltd.
Plot No:438, SPR Arcade,
1st Floor, TNGO’s Colony Phase 2
Gachibowli, Hyderabad-500032
Telangana, India.
Our locationsWhere to find us?
https://www.prometheusip.com/wp-content/uploads/2020/01/footer-map.png
Get in touchPrometheus IP Social

Copyright Prometheus IP. All rights reserved.

Copyright Prometheus IP. All rights reserved.